• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人食管癌的当前及未来治疗选择

Current and future treatment options for esophageal cancer in the elderly.

作者信息

Bollschweiler Elfriede, Plum Patrick, Mönig Stefan P, Hölscher Arnulf H

机构信息

a Department of General, Visceral and Cancer Surgery , University of Cologne , Köln , Germany.

b Service de Chirurgie viscéral , Hôpitaux Universitaires de Genève , Geneva , Switzerland.

出版信息

Expert Opin Pharmacother. 2017 Jul;18(10):1001-1010. doi: 10.1080/14656566.2017.1334764. Epub 2017 Jun 7.

DOI:10.1080/14656566.2017.1334764
PMID:28540761
Abstract

Esophageal cancer is the eighth most common cancer globally and has the sixth worst prognosis because of its aggressiveness and poor survival. Data regarding cancer treatment in older patients is limited because the elderly have been under-represented in clinical trials. Therefore, we reviewed the existing literature regarding treatment results for elderly patients (70+ years). Areas covered: We used pubmed to analyze the actual literature according to elderly esophageal cancer patients with subheading of incidence, esophagectomy, chemoradiation or chemotherapy. The main points of interest were treatment options for patients with Barrett's esophagus or early carcinoma, advanced tumor stages, and inoperable cancer. Expert opinion: The incidence of esophageal cancer has been increasing over the past thirty years, with a rapid increase of esophageal adenocarcinoma in Western industrialized nations. Patients aged over 60 years have been particularly affected. In this review, we have shown that elderly patients with esophageal cancer have various alternatives for adequate treatment. Clinical evaluation of comorbidity is necessary to make treatment decisions. Therapeutic options for early carcinomas are endoscopic or surgical resection. For elderly patients with advanced carcinomas, preoperative chemoradiation or chemotherapy should be discussed.

摘要

食管癌是全球第八大常见癌症,因其侵袭性和低生存率而成为预后第六差的癌症。由于老年患者在临床试验中的代表性不足,关于老年患者癌症治疗的数据有限。因此,我们回顾了有关老年患者(70岁及以上)治疗结果的现有文献。涵盖领域:我们使用PubMed根据老年食管癌患者的发病率、食管切除术、放化疗或化疗等副标题来分析实际文献。主要关注点是巴雷特食管或早期癌、晚期肿瘤阶段以及无法手术的癌症患者的治疗选择。专家意见:在过去三十年中,食管癌的发病率一直在上升,在西方工业化国家,食管腺癌的发病率迅速增加。60岁以上的患者受影响尤为严重。在本综述中,我们表明老年食管癌患者有多种适当的治疗选择。进行合并症的临床评估对于做出治疗决策很有必要。早期癌的治疗选择是内镜或手术切除。对于老年晚期癌患者,应讨论术前放化疗或化疗。

相似文献

1
Current and future treatment options for esophageal cancer in the elderly.老年人食管癌的当前及未来治疗选择
Expert Opin Pharmacother. 2017 Jul;18(10):1001-1010. doi: 10.1080/14656566.2017.1334764. Epub 2017 Jun 7.
2
Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancer.新辅助治疗对老年食管癌患者行食管切除术后围手术期发病率的影响。
Ann Surg Oncol. 2007 Nov;14(11):3243-50. doi: 10.1245/s10434-007-9455-z. Epub 2007 Aug 23.
3
Treatment of Barrett's esophagus with high-grade dysplasia.巴雷特食管伴高级别异型增生的治疗。
Expert Rev Anticancer Ther. 2009 Mar;9(3):303-16. doi: 10.1586/14737140.9.3.303.
4
Does Barrett's esophagus respond to chemoradiation therapy for adenocarcinoma of the esophagus?巴雷特食管对食管腺癌的放化疗有反应吗?
Gastrointest Endosc. 2010 Feb;71(2):235-40. doi: 10.1016/j.gie.2009.09.038. Epub 2009 Dec 8.
5
CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cTNM) (NCT03001596).CMISG1701:一项多中心前瞻性随机III期临床试验,比较新辅助放化疗与新辅助化疗后行微创食管切除术在局部晚期可切除食管鳞状细胞癌(cTNM)患者中的疗效(NCT03001596)。
BMC Cancer. 2017 Jun 28;17(1):450. doi: 10.1186/s12885-017-3446-7.
6
Endoscopic versus surgical therapy for early cancer in Barrett's esophagus: a decision analysis.内镜治疗与手术治疗 Barrett 食管早期癌的决策分析
Gastrointest Endosc. 2009 Oct;70(4):623-31. doi: 10.1016/j.gie.2008.11.047. Epub 2009 Apr 25.
7
Barrett's esophagus (BE) and carcinoma in the esophageal stump (ES) after esophagectomy with gastric pull-up in achalasia patients: a study based on 10 years follow-up.贲门失弛缓症患者行食管胃提拉式食管切除术后的 Barrett 食管(BE)及食管残端癌(ES):一项基于 10 年随访的研究
Ann Surg Oncol. 2008 Oct;15(10):2903-9. doi: 10.1245/s10434-008-0057-1. Epub 2008 Jul 10.
8
Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients.局部晚期食管腺癌的多模态治疗:我们应该选择哪种方案?105 例患者围手术期化疗与新辅助放化疗的疗效分析。
J Surg Oncol. 2014 Mar;109(3):287-93. doi: 10.1002/jso.23498. Epub 2013 Nov 26.
9
Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.新辅助放化疗和食管切除术后辅助化疗在食管癌中的应用。
Ann Surg. 2017 Aug;266(2):297-304. doi: 10.1097/SLA.0000000000001954.
10
Neoadjuvant chemoradiation for locally advanced resectable carcinoma of the esophagus: A single-center experience from India with a brief review of the literature.新辅助放化疗用于局部晚期可切除食管癌:来自印度的单中心经验及文献简要综述
Indian J Cancer. 2017 Oct-Dec;54(4):646-651. doi: 10.4103/ijc.IJC_452_17.

引用本文的文献

1
Neoadjuvant chemoradiation in older Irish adult patients with oesophageal cancer: a retrospective institutional review of clinical outcomes and hematological toxicity.爱尔兰老年食管癌成年患者的新辅助放化疗:临床结局和血液学毒性的回顾性机构研究
BMC Cancer. 2025 Aug 7;25(1):1280. doi: 10.1186/s12885-025-14055-6.
2
Postoperative Serum Interleukin 6 Concentrations Are Associated With Nutritional Status and Prognosis of Esophageal Cancer in the Minimally Invasive Esophagectomy Era.微创食管切除时代,术后血清白细胞介素6浓度与食管癌的营养状况及预后相关。
Ann Surg Oncol. 2025 May 24. doi: 10.1245/s10434-025-17489-1.
3
Comparison of machine learning methods for Predicting 3-Year survival in elderly esophageal squamous cancer patients based on oxidative stress.
基于氧化应激的老年食管鳞癌患者 3 年生存预测的机器学习方法比较。
BMC Cancer. 2024 Nov 21;24(1):1432. doi: 10.1186/s12885-024-13115-7.
4
Machine learning-based prediction of 5-year survival in elderly NSCLC patients using oxidative stress markers.基于机器学习,利用氧化应激标志物预测老年非小细胞肺癌患者的5年生存率
Front Oncol. 2024 Oct 24;14:1482374. doi: 10.3389/fonc.2024.1482374. eCollection 2024.
5
Neoadjuvant chemotherapy plus immunotherapy for locally advanced esophageal cancer.新辅助化疗联合免疫疗法治疗局部晚期食管癌。
Am J Transl Res. 2024 Sep 15;16(9):4840-4848. doi: 10.62347/KTPZ5454. eCollection 2024.
6
Association between preoperative serum zinc level and prognosis in patients with advanced esophageal cancer in the neoadjuvant treatment era.新辅助治疗时代晚期食管癌患者术前血清锌水平与预后的关系
Ann Gastroenterol Surg. 2024 Mar 6;8(4):595-603. doi: 10.1002/ags3.12781. eCollection 2024 Jul.
7
LINC00963 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma by Interacting with miR-10a to Upregulate SKA1 Expression.LINC00963 通过与 miR-10a 相互作用上调 SKA1 表达促进食管鳞癌顺铂耐药。
Appl Biochem Biotechnol. 2024 Oct;196(10):7219-7232. doi: 10.1007/s12010-024-04897-4. Epub 2024 Mar 20.
8
Age-period-cohort analysis of incidence, mortality and disability-adjusted life years of esophageal cancer in global, regional and national regions from 1990 to 2019.1990 年至 2019 年全球、区域和国家地区食管癌发病率、死亡率和伤残调整生命年的年龄-时期-队列分析。
BMC Public Health. 2024 Jan 17;24(1):212. doi: 10.1186/s12889-024-17706-8.
9
Effects of different anesthesia methods on perioperative immune function and long-term regression of patients undergoing thoracoscopic radical esophagectomy for esophageal cancer.不同麻醉方法对食管癌胸腔镜根治术患者围手术期免疫功能及远期预后的影响
Heliyon. 2023 Nov 25;9(12):e22822. doi: 10.1016/j.heliyon.2023.e22822. eCollection 2023 Dec.
10
Circ_0001944 depletion inhibits glycolysis and esophageal cancer progression by binding to miR-338-5p to reduce PDK1 expression.Circ_0001944缺失通过与miR-338-5p结合以降低PDK1表达来抑制糖酵解和食管癌进展。
J Bioenerg Biomembr. 2024 Feb;56(1):73-85. doi: 10.1007/s10863-023-09988-1. Epub 2023 Nov 24.